Cullinan Oncology shareholders re-elect Gadicke and Rosenberg as directors, ratify KPMG

Cullinan Therapeutics, Inc.

Ansbert Gadicke elected with 27,033,605 votes for, 10,667,725 withheld, 4,141,978 broker non-votes.
Anthony Rosenberg elected with 27,229,454 votes for, 10,471,876 withheld, same broker non-votes.
KPMG ratified as independent auditor for FY2022: 41,825,399 for, 12,030 against, 5,879 abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.